Therapeutic Advances in Gastroenterology
ISSN:1756-283X

Therapeutic Advances in Gastroenterology

THER ADV GASTROENTER
学科领域:医学
是否预警:不在预警名单内
是否OA:
录用周期:15 Weeks
新锐分区:医学3区
年发文量:133
影响因子:3.4
JCR分区:Q2

基本信息

《 胃肠 病学 治疗 进展 》 是 一 本 开放 获取 期刊 , 提供 最 高 质量 的 同行 评审 原创 研究 文章 、 综述 和 学术 评论 , 内容 涉及 胃肠 和 肝脏 疾病 医学 治疗 的 开创 性 努力 和 创新 研究 。该 杂志 以 临床 和 药理 学 为 重点 , 面向 胃肠 病学 和 相关 学科 的 临床 医生 和 研究 人员 的 国际 读者 , 提供 了 一 个 快速 传播 该 领域 最 新 研究 和 观点 的 在线 论坛 。 编辑 欢迎 胃肠 病学 和 肝病 学 所有 领域 的 原创 研究 文章 。 该 杂志 主要 发表 原创 研究 文章 和 综述 文章 。原始 研究 手稿 可能 包括 实验 室 、 动物 或 人体/临床 研究 - 所有 阶段 。读者 来信 及 个案 报告 亦 会 一并 考虑 。
1756-283XSCIE/Scopus收录/DOAJ开放期刊
3.4
3.7
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学3区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
3区
N/A
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科:GASTROENTEROLOGY & HEPATOLOGY
SCIE
Q2
47/148
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科:GASTROENTEROLOGY & HEPATOLOGY
SCIE
Q2
61/148
42
133
13%-15 WeeksUSD2700GASTROENTEROLOGY & HEPATOLOGY-
2.9%
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
75.19%98.76%-
CiteScore:6.70
SJR:1.370
SNIP:1.113
学科类别分区排名百分位
大类:Medicine
小类:Gastroenterology
Q1
32 / 173

期刊高被引文献

The gut virome: the ‘missing link’ between gut bacteria and host immunity?
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819836620
Insights into the role of fecal microbiota transplantation for the treatment of inflammatory bowel disease
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819836893
Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819884196
Insights into the evolving role of the gut microbiome in nonalcoholic fatty liver disease: rationale and prospects for therapeutic intervention
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819858470
Meta-analysis of individual patient data of albumin dialysis in acute-on-chronic liver failure: focus on treatment intensity
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819879565
Management of Clostridioides difficile colitis: insights for the gastroenterologist
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819847651
Current status of first- and second-line Helicobacter pylori eradication therapy in the metropolitan area: a multicenter study with a large number of patients
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819858511
Targeting mucosal healing in Crohn’s disease: what the clinician needs to know
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819856865
Insights into the role of cannabis in the management of inflammatory bowel disease
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819870977
Practical guidance for the management of inflammatory bowel disease in patients with cancer. Which treatment?
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284818817293
Incidence of inflammatory bowel disease by race and ethnicity in a population-based inception cohort from 1970 through 2010
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819827692
Susceptibility-guided therapy for Helicobacter pylori infection treatment failures
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819874922
Impact of the gut microbiota on immune checkpoint inhibitor-associated toxicities
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819870911
Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819878046
Characterization of the prognostic values of the NDRG family in gastric cancer
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819858507
The anti-inflammatory potential of diet and nonalcoholic fatty liver disease: the ATTICA study
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819858039
Nutritional interventions for the treatment of IBD: current evidence and controversies
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819890534
Burden of drug use for gastrointestinal symptoms and functional gastrointestinal disorders in France: a national study using reimbursement data for 57 million inhabitants
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819853790
Acute and subacute effects of oropharyngeal sensory stimulation with TRPV1 agonists in older patients with oropharyngeal dysphagia: a biomechanical and neurophysiological randomized pilot study
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819842043
Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn’s disease, a post hoc analysis
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819881590
18F-fludeoxyglucose positron emission tomography for diagnosis of HCC: implications for therapeutic strategy in curative and non-curative approaches
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819836205
Metabolic bone disease in patients diagnosed with inflammatory bowel disease from Spain
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819862152
Gastrointestinal and liver diseases and atrial fibrillation: a review of the literature
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819832237
An expansion study of genotype-driven weekly irinotecan and capecitabine in combination with neoadjuvant radiotherapy for locally advanced rectal cancer with UGT1A1 *1*1 genotype
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819852293
Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819878660
What forecasting the prevalence of inflammatory bowel disease may tell us about its evolution on a national scale
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819860044
Long-term follow up after switching from original infliximab to an infliximab biosimilar: real-world data
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819858052
The ‘totality-of-the-evidence’ approach in the development of PF-06438179/GP1111, an infliximab biosimilar, and in support of its use in all indications of the reference product
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819852535
A nomogram for predicting the response to exclusive enteral nutrition in adult patients with isolated colonic Crohn’s disease
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819881301
Lifestyle intervention for gastroesophageal reflux disease: a national multicenter survey of lifestyle factor effects on gastroesophageal reflux disease in China
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819877788
Accuracy of the new rapid test for monitoring adalimumab levels
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819828238
Association of serum albumin level with incidence and mortality of overt hepatic encephalopathy in cirrhosis during hospitalization
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819881302
Safety and effectiveness of multi-antenna microwave ablation-oriented combined therapy for large hepatocellular carcinoma
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819862966
Clinical and endoscopic features of severe acute gastrointestinal bleeding in elderly patients treated with direct oral anticoagulants: a multicentre study
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819851677
Metabolic syndrome is a risk factor for colorectal adenoma and cancer: a study in a White population using the harmonized criteria
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819867839
Mass spectrometry-based metabolomics for irritable bowel syndrome biomarkers
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819886425
De-escalating chemotherapy for stage II colon cancer?
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819867553
Endoscopy in inflammatory bowel disease: from guidelines to real life
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819865153
Vitamin D metabolites are lower with active Crohn’s disease and spontaneously recover with development of remission
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819865144
Risk factors for Barrett’s esophagus in young adults who underwent upper gastrointestinal endoscopy in a health examination center
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819853115
Proton-pump inhibitors do not influence clinical outcomes in patients with Staphylococcus aureus bacteremia
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819834273
Transcribed ultraconserved region (T-UCR) uc.261 expression is closely correlated with disease activity and intestinal permeability in Crohn’s disease
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819880733
Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819867848
The duration of acupuncture effects and its associated factors in chronic severe functional constipation: secondary analysis of a randomized controlled trial
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819881859
Anorectal biofeedback: an effective therapy, but can we shorten the course to improve access to treatment?
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819836072
Predicting factors of recurrence in patients with gastroesophageal reflux disease: a prospective follow-up analysis
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819864549
Effectiveness of endoscopic ultrasound-guided drainage for noncapsulated postoperative pancreatic collection
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819884418
Simultaneous analyses of carbohydrate-mediated serum GLP-1 and GLP-2 and duodenal receptor expression in children with and without celiac disease
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819842756
Efficacy of dexlansoprazole-based triple therapy for Helicobacter pylori infections
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819870960
Clinical response to linaclotide at week 4 predicts sustained response in irritable bowel syndrome with constipation and improvements in digestive and extra-digestive symptoms
来源期刊:Therapeutic Advances in GastroenterologyDOI:10.1177/1756284819857358

相关文章

2026年3月发布
大类学科小类学科Top期刊综述期刊
医学3区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
3区
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学3区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
4区
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学3区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
4区